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a b s t r a c t
Background: Infants too young to be fully vaccinated are vulnerable to potentially deadly influenza and
pertussis infections. The cocooning strategy limits this risk by vaccinating those likely to interact with
the infant and mother during this vulnerable time, such as close friends and family members.
Distribution of accurate and accessible vaccine information through existing social networks could be
an important tool in increasing vaccine confidence and coverage.
Methods: We surveyed 1095 pregnant women from diverse prenatal care practices in Georgia and
Colorado. These women were surveyed through a mobile app to assess vaccine intentions, attitudes,
beliefs, norms, and levels of trust, and then presented brief individually-tailored educational videos about
maternal and infant vaccines and the cocooning strategy. They were then given the opportunity to refer
up to six contacts to enroll in the app and receive similar vaccine education.
Results: Twenty-eight percent of these women referred at least one contact, with an average of 2.67 con-
tacts per referring woman. Most referrals (93%) were partners, parents, siblings, relatives, or close friends.
Attitudinal constructs significantly associated with increased likelihood of referring contacts included:
intention to receive maternal influenza vaccine, perceived safety of maternal Tdap vaccine, perceived effi-
cacy of maternal influenza vaccine, perceived susceptibility to and severity of influenza during preg-
nancy, and trust in vaccine information from the Centers for Disease Control and Prevention (CDC) and
academic institutions. Uncertainty about infant vaccine intentions was associated with decreased likeli-
hood of referring contacts.
Conclusions: Pregnant women who valued vaccination and trusted vaccine information from academic
institutions were more likely to refer an educational app about vaccines than those who did not.
Further research is needed to determine the potential impact of this strategy on vaccine coverage when
implemented on a large scale.
https://doi.org/10.1016/j.vaccine.2020.02.019
0264-410X/ 2020 Elsevier Ltd. All rights reserved.
⇑ Corresponding author at: 615 N Wolfe St, W5041, Baltimore, MD 21205, United States.
E-mail address: mattdudley@jhu.edu (M.Z. Dudley).
Vaccine 38 (2020) 2827–2832
Contents lists available at ScienceDirect
Vaccine
journal homepage: www.elsevier .com/locate /vacc ine
Trial Registration: The survey informing this article was part of a randomized controlled trial funded by
the National Institutes of Health [clinicaltrials.gov registration number NCT02898688].
 2020 Elsevier Ltd. All rights reserved.
1. Introduction
Children too young to be vaccinated against pertussis are at
high risk for contracting pertussis disease (commonly known as
whooping cough); they also have the highest complication rates
[1–4]. Almost all pertussis deaths in the United States (US) occur
in children less than 6 months of age [1,2]. For influenza, there is
no licensed vaccine for infants less than 6 months of age, and this
is the group at highest risk for influenza-associated hospitalization
and death [5]. Influenza and tetanus, diphtheria and acellular per-
tussis (Tdap) vaccines are recommended during pregnancy to pro-
tect both the pregnant woman and her unborn infant against these
diseases [2,6–8]. Only about half of pregnant women receiving
either recommended vaccine in 2018 [9]. This leaves many infants
vulnerable to potentially deadly influenza and pertussis infections
in their early life [4,5,8,10].
Cocooning, the vaccination of close contacts of a newborn, is a
strategy to further limit the risk of influenza and pertussis infection
among vulnerable infants [11–13]. Factors such as high perceived
benefits of vaccine, high perceived susceptibility to disease, and
low perceived barriers to vaccination have been associated with
higher rates of cocooning vaccination [14], illustrating the poten-
tial for educational intervention on this topic.
Vaccine decisions, like many other types of decisions, have been
shown to be influenced by one’s peers within their social network
[15–19], especially among those with vaccine concerns [20]. Thus,
by changing the vaccine attitudes and beliefs of a pregnant
woman’s social network, one may also change the vaccine atti-
tudes and beliefs of that pregnant woman, and vice versa. Only
one study so far has analyzed social networks to determine their
impact on vaccine decision making in the US [18].
We designed an educational app about vaccines that pregnant
women could experience and refer to their close friends and fam-
ily, with the goal of increasing vaccine coverage among both preg-
nant women and their close contacts. The main objective of this
analysis was to determine which factors were associated with an
increased likelihood of pregnant women referring their close con-
tacts to this educational app. A secondary objective was to deter-
mine the types of contacts (e.g., partner, parent, sibling, other
relative, close friend, casual friend, caregiver, other) most com-
monly referred and enrolled in the app.
2. Methods
2.1. Study design
This study was possible due to the existing infrastructure of the
P3+ study, a large randomized controlled trial of a three-level pre-
natal intervention to increase uptake of maternal and infant vacci-
nes [clinicaltrials.gov registration number NCT02898688]. In P3+,
pregnant women entering a geographically and socio-
demographically diverse set of prenatal care settings in Georgia
(GA) and Colorado (CO) for regularly scheduled appointments
between June 2017 and July 2018 were recruited to participate
by study staff. Eligibility criteria mandated that participating
women must have been between 18 and 50 years old, between 8
and 26 weeks pregnant, and had not yet received Tdap vaccine dur-
ing their current pregnancy.
As part of the P3+ study, we developed an application (‘‘app”)
for pregnant women entitled ‘‘MomsTalkShots” that can be used
on smartphones, tablets and computers [21]. The app was designed
to collect survey data on vaccine knowledge, attitudes and beliefs
and to deliver educational videos about maternal and infant vacci-
nes and the cocooning strategy, tailored to the individual’s specific
vaccine concerns as elicited by their survey responses. The baseline
survey was administered to all P3+ participants via tablets in the
waiting rooms, and a $20 incentive was provided for survey com-
pletion [21]. Videos were only given to half of the participants, cho-
sen at random. Videos were designed to present information in a
scientifically accurate yet engaging manner with easily under-
standable language and representations of racially and ethnically
diverse populations. This was done so that the app would have
broad appeal to a variety of audiences with varying audiences.
All participating women randomized to receive videos were
given the opportunity to refer up to 6 of their close friends and
family to the app upon conclusion of the videos. Those who
referred at least one contact received a $10 gift card. Two-thirds
of the referred contacts selected at random were then sent up to
10 emails, each spaced out by at least a week, with a link to the
app inviting them to enroll. As in P3+, referred contacts who chose
to enroll in the app were incentivized ($20 gift card) to complete a
survey and randomized (1:1) to receive individually-tailored edu-
cational videos. Enrolled contacts also were offered a small finan-
cial incentive ($10 worth of Walgreens Balance Rewards points
per vaccine) for receiving influenza and/or Tdap vaccinations at
Walgreens.
2.2. Data collection
The baseline P3+ survey included multiple choice questions
assessing intention to receive recommended maternal and infant
vaccines and number of prior children. In addition, the survey
included 58 Likert scale statements assessing latent attitudinal
constructs such as: confidence in vaccine safety and efficacy, per-
ceived risk of (susceptibility to and severity of) vaccine-
preventable diseases (VPDs), self-efficacy (an individual’s belief
in their capacity to execute behaviors necessary to produce specific
performance attainments) [22], descriptive (what people typically
do) and injunctive (what people typically approve or disapprove)
social norms [23], perception of knowledge, and trust in informa-
tion sources. These were chosen after reviewing other relevant
behavioral models, theories and scales [15,24], and each construct
was assessed using several survey items. Likert scale response
options were strongly agree, agree, disagree, and strongly disagree;
trust and knowledge statements included a ‘‘don’t know” option;
and trust statements regarding pediatricians and naturopathic/chi-
ropractic doctors included options for ‘‘I don’t have a pediatrician
yet” and ‘‘I don’t see this type of doctor”, respectively. Sociodemo-
graphic information including ethnicity and education was
collected.
2.3. Data analysis
Responses to questions assessing maternal and infant vaccine
intention were dichotomized to represent those who intended to
receive maternal influenza vaccine, those who intended to receive
maternal Tdap vaccine, and those who intended to receive all
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infant vaccines on time as recommended (versus those who did
not). Likert scale responses were dichotomized to represent those
who strongly agreed or agreed versus those who did not.
Likert scale responses were encoded (1 - strongly disagree, 2 -
disagree, 3 - don’t know, 4 - agree, 5 - strongly agree) and survey
questions assessing each of the following attitudinal constructs
were combined to create summary scores: confidence in vaccine
safety (for the mother), confidence in vaccine safety (for the
infant), confidence in vaccine efficacy (influenza), confidence in
vaccine efficacy (whooping cough), risk perception (maternal
influenza), risk perception (maternal whooping cough), risk per-
ception (infant whooping cough), self-efficacy, social norms, per-
ception of vaccine knowledge, trust in vaccine information (from
pediatricians, obstetricians and midwives), trust in vaccine infor-
mation (from naturopaths and chiropractors), and trust in vaccine
information (from federal agencies and academic institutions).
Sociodemographic characteristics, individual survey responses,
and construct summary scores were each analyzed as independent
variables in simple logistic regressions with a dichotomous vari-
able for having referred contacts versus not having referred con-
tacts as the dependent variable, and odds ratios (ORs) and 95%
confidence intervals (95%CIs) were calculated.
Percentages of contacts referred and enrolled in the app by type
of relationship to the referrer were calculated. Pearson’s chi-
squared test for independence was used to assess differences in
enrollment rates by relationship type. All p-values were two-
sided, and p < 0.05 was considered statistically significant. Analysis
was performed using Stata/IC 12.1 (STATA Corp., College Station,
TX, USA).
3. Results
Among pregnant women participating in P3+, 1095 (542 from
Colorado and 553 from Georgia) were randomized to receive
videos and thus were given the opportunity to refer contacts to
the app (Table 1). Forty-eight percent of these women were preg-
nant for the first time. Of those who provided education informa-
tion (n = 894, 82% of total sample), 227 (25%) had an advanced
degree and 389 (44%) had an associate’s or bachelor’s degree. Of
those who provided their ethnicity (n = 926, 85% of total sample),
569 (61%) identified as white; 158 (17%) identified as black and
115 (12%) as Hispanic or Latino.
Three hundred and six women (28%) referred at least one con-
tact to the app, with an average of 2.67 contacts per referring
woman. Of these women, 39% referred one contact, 22% referred
two contacts, 11% referred three contacts, 6% referred four con-
tacts, 3% referred five contacts, and 18% referred the maximum of
six contacts (Table 2).
A total of 819 contacts were referred (Table 3). Twenty-four
percent of referred contacts were listed as parents, 20% as close
friends, 19% as partners, 16% as siblings, 14% as other relatives,
2% as casual friends, 2% as caregivers to the infant, and 2% as other.
Several statistically significant associations were found
between pregnant women who referred contacts and survey items
assessing their vaccine intentions, knowledge, attitudes, beliefs
and trust (Table 4). Women who intended to receive maternal
influenza vaccine were more likely to refer contacts to the app
(odds ratio: 1.37; 95% confidence interval: 1.04–1.81), and women
who were unsure about their infant vaccine intentions were less
likely to refer contacts to the app (OR: 0.47; 95%CI: 0.27–0.83).
Women were more likely to refer contacts to the app if they were
confident in the safety of maternal Tdap vaccine (OR: 1.64; 95%CI:
1.13–2.38) and the efficacy of maternal influenza vaccine (OR:
1.90; 95%CI: 1.21–2.98), had high perceived susceptibility to (OR:
1.62; 95%CI: 1.10–2.40) and severity of (OR: 2.19; 95%CI: 1.28–
3.73) influenza during pregnancy, and reported trust in maternal
vaccine information from academic institutions (OR: 1.56; 95%CI:
1.09–2.25) as well as infant vaccine information from the CDC
(OR: 1.44; 95%CI: 1.02–2.05) and academic institutions (OR:
1.85; 95%CI: 1.27–2.71). Attitudinal constructs found to be signifi-
Table 1
Percentage of pregnant women who referred contacts to educational App about
vaccines, stratified by state, education, ethnicity and first child.
Selected characteristics Total, N (%) Referred contacts, N (%)* P**
All 1095 306 (28)
State
Colorado 542 (50) 157 (29) 0.46
Georgia 553 (51) 149 (27)
total 1,095 306 (28)
Education
Graduate degree*** 227 (25) 82 (36) 0.03
Undergraduate degree*** 389 (44) 107 (28)
No college degree 278 (31) 72 (26)
total 894 261 (29)
Ethnicity
Black or African American 158 (17) 39 (25) 0.15
Hispanic or Latino 115 (12) 35 (30)
White 569 (61) 158 (28)
Other 84 (9) 32 (38)
total 926 264 (29)
First Child
Yes 523 (48) 150 (29) 0.60
No 572 (52) 156 (27)
total 1,095 306 (28)
* Number and percentage in each sociodemographic group who referred contacts
to app.
** P-value for the Pearson chi-squared proportion test at significance level of (a)
5%; bolded if significant.
*** Graduate degree includes Master’s, Doctoral, and Professional degrees; Under-
graduate degree includes Bachelor’s and Associate’s degrees.
Table 2
Number of contacts referred to educational app about
vaccines per pregnant woman.








6 (maximum allowed) 56 (5)
total 1,095 (1 0 0)
Table 3
Contacts referred to educational app about vaccines by
relationship to pregnant women who referred them.




Other Relative 118 (14)
Close Friend 162 (20)
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cantly associated with referral of contacts were: confidence in vac-
cine safety for the mother (OR: 1.10; 95%CI: 1.03–1.17), perceived
risk of maternal influenza (OR: 1.15; 95%CI: 1.06–1.26), confidence
in efficacy of influenza (OR: 1.14; 95%CI: 1.03–1.26) and whooping
cough (OR: 1.08; 95%CI: 1.01–1.15) vaccines, and trust in vaccine
information from federal agencies and academic institutions (OR:
1.07; 95%CI: 1.03–1.12). There were no statistically significant
associations between likelihood of referring contacts to the app
and ethnicity, education, state, or having prior children.
Four hundred eighty-five (59%) of the contacts referred were
randomly selected to be invited by email to join the study and
enroll in the app (Table 5). Of these, 158 enrolled in the app (33%
response rate). No statistically significant difference in enrollment
rates by type of relationship to the referring pregnant woman was
found (p = 0.56).
4. Discussion
Pregnant women were more likely to refer their friends and
family to an educational app about vaccines if they were confident
in the safety and efficacy of maternal vaccines, perceived risk of
influenza during pregnancy, and trusted vaccine information from
federal agencies and academic institutions.
The vast majority of contacts referred to an educational app
about vaccines by pregnant women were their partners, parents,
siblings, relatives, or close friends. Very few users referred their
casual friends or other caregivers for the infant. This is not surpris-
ing; women may be more comfortable referring close friends and
family than caregivers with whom they do not have the same per-
sonal relationship. However, from a public health perspective,
caregivers would be an ideal target for cocooning vaccinations,
and ways to increase their inclusion in referral strategies such as
this should be explored. No difference was seen in the likelihood
of the referred contact enrolling in the app based on the type of
relationship with the referring pregnant woman.
The positive association found between referring contacts to the
app and trust in vaccine information from academic institutions is
logical, as the app was clearly labeled as a product of the three uni-
versities collaborating on this study (Emory University, University
of Colorado Anschutz Medical Campus, and Johns Hopkins Bloom-
berg School of Public Health). Previous vaccine-related studies
have similarly identified institutional trust is strongly correlated
with immunization intent, vaccine trial participation, and reported
vaccine receipt [19,25,26].
The significant association of confidence in vaccine safety and
efficacy and perceived risk of VPDs with contact referral suggests
that a perceived lack of benefit of vaccination may decrease desire
to share an educational app about vaccines with friends and family,
which is consistent with a previous study [14]. Perceived pro-
vaccine attitudes of women’s friends and family was positively
yet non-significantly (P = 0.06) associated with referring them to
an educational app about vaccines. Social norms and the influences
of others have been previously linked to maternal influenza vac-
cine receipt in similar clinical studies involving message framing
[27–29]. Women may be more comfortable sharing information
with their family and friends that they knew would resonate with
their pre-existing beliefs; or perhaps that some were hesitant to
share information they thought would be contradictory to their
family and friends’ pre-existing beliefs. This would align with
existing research on the ‘‘echo chamber” effect on online spread
of vaccine information [30], and may limit the ability of this refer-
ral strategy to decrease vaccine hesitancy if most referred contacts
are already confident in vaccines. Even if true, the current strategy
could still have an impact on vaccine coverage through the rein-
forcement of the importance of vaccination to an audience predis-
posed to agree with this message. However, to make the largest
possible impact on vaccine confidence and uptake, effective meth-
ods for bypassing the echo chamber effect would need to be devel-
oped and confirmed through future research.
Women with uncertain infant vaccine intentions were less
likely to refer contacts to the app than those who had already made
Table 4
Odds ratios for survey items and attitudinal constructs associated with pregnant
women referring contacts to educational app about vaccines.
Survey Items Contacts Referred,
OR (95%CI)*
Vaccine Intentions**
Intention to Receive Maternal Influenza Vaccine 1.37 (1.04, 1.81)
Uncertain Infant Vaccine Intentions 0.47 (0.27, 0.83)
Individual Survey Statements - Agreed or Strongly Agreed**
Confidence in Vaccine Safety
I am confident that getting the whooping cough
vaccine during my pregnancy is safe for me.
1.64 (1.13, 2.38)
Other Vaccine Knowledge, Attitudes and Beliefs
I worry that I could get the flu while I am pregnant. 1.62 (1.10, 2.40)
The flu is more dangerous for pregnant women than
for women who are not pregnant.
2.19 (1.28, 3.73)
Getting the flu vaccine will reduce my risk of getting
the flu during my pregnancy.
1.90 (1.21, 2.98)
I trust the information provided by federal agencies
such as the Centers for Disease Control and
Prevention (CDC) about vaccines for babies after
birth.
1.44 (1.02, 2.05)
I trust the information provided by scientists and
doctors at universities and academic institutions
about vaccines during pregnancy.
1.56 (1.09, 2.25)
I trust the information provided by scientists and
doctors at universities and academic institutions
about vaccines for babies after birth.
1.85 (1.27, 2.71)
Attitudinal Constructs - Summary Scores***
Confidence in vaccine safety (for the mother) 1.10 (1.03–1.17)
Confidence in vaccine safety (for the infant) 1.03 (0.98–1.09)
Confidence in vaccine efficacy (influenza) 1.14 (1.03–1.26)
Confidence in vaccine efficacy (whooping cough) 1.08 (1.01–1.15)
Perceived risk (maternal influenza) 1.15 (1.06–1.26)
Perceived risk (maternal whooping cough) 0.96 (0.85–1.08)
Perceived risk (infant whooping cough) 1.02 (0.96–1.08)
Self-efficacy 1.03 (0.87–1.22)
Pro-vaccine social norms 1.04 (1.00–1.09)
Perception of vaccine knowledge 1.06 (0.99–1.14)
Trust in vaccine information (from obstetricians and
pediatricians****)
1.02 (0.98–1.05)
Trust in vaccine information (from naturopaths and
chiropractors****)
0.93 (0.87–1.00)
Trust in vaccine information (from federal agencies
and academic institutions)
1.07 (1.03–1.12)
* Odds Ratio (95% Confidence Interval) for referring contacts to app.
** Survey items only listed if statistically significantly associated with referring
contacts to app.
*** Construct summary scores all listed, bolded if significant.
**** Removed those who stated they hadn’t yet seen this type of provider from this
analysis.
Table 5
Contacts who chose to enroll in educational app about vaccines by relationship to
pregnant women who referred them.**
Relationship Enrolled, N (%) Not Enrolled, N (%) Total*
Partner 34 (39) 54 (61) 88
Parent 31 (29) 77 (71) 108
Sibling 19 (25) 57 (75) 76
Other Relative 25 (33) 50 (67) 75
Close Friend 39 (38) 64 (62) 103
Casual Friend 4 (33) 8 (67) 12
Caregiver 3 (38) 5 (63) 8
Other 2 (18) 9 (82) 11
Unknown 1 (25) 3 (75) 4
total* 158 (33) 327 (67) 485
* Only 485 of 819 referred contacts (59%) invited to enrol.
** Pearson chi-squared (8) = 6.76 ; p-value = 0.56.
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up their mind, perhaps implying limited utility of this strategy in
helping uncertain women formulate positive infant vaccine inten-
tions by educating their social network. However, no statistically
significant effect was seen for women with uncertain maternal
vaccine intentions, for which much greater frequency of uncer-
tainty existed.
The ethnicity, education and state of residence (CO vs GA) of the
pregnant women using the MomsTalkShots app did not appear to
impact their likelihood of referring contacts, nor did having prior
children. These data may indicate the broad appeal of this app
and referral strategy to the general population regardless of ethnic-
ity or education level.
This study has several limitations. First, these data are not
nationally generalizable. This study was embedded into an existing
study analyzing a comprehensive intervention to increase vaccina-
tion among pregnant women; the pregnant women who chose to
enroll in the preexisting trial and were available to participate in
this study may be different than those who did not participate in
the study and therefore pregnant women in general. In addition,
the income level of pregnant women participating in this study
was not collected, so we are unable to properly control for this in
our analysis. Because pregnant women were offered a $10 gift card
as an incentive for referring contacts to the app, their primary
motivation may have been to do so to receive financial incentive,
instead of the factors we measured and analyzed. However, some-
what reassuring is that having at least a college degree was not sta-
tistically significantly associated with referring contacts to the app,
as education is generally associated with income status [31]. Since
vaccine intentions were assessed before the videos but referral was
available after the videos, any short-term effect of the videos on
the decision to refer contacts was not captured by this analysis.
Whether a referred contact enrolled in the app or not may have
been impacted by email habits and spam filters, which may explain
why no statistically significant difference was seen in likelihood of
enrolling in the app by type of relationship with the referring preg-
nant woman.
As providing financial incentives for referring contacts would
likely be impractical on a large scale, further research into the
impact and sustainability of this type of app referral strategy with-
out incentives is needed. Qualitative research on the specific rea-
sons for referring and not referring such apps would complement
quantitative research such as this. Further research is also needed
to assess whether vaccination attitudes, intentions and uptake are
impacted among referred contacts, and whether this in turn has
any effect on the referring pregnant woman. If successful, such a
strategy could increase vaccine confidence and coverage for very
little cost, by spreading accurate, individually tailored vaccine
information through existing social networks of pregnant women.
This app referral strategy could also be refined for populations
other than pregnant women, to widen its potential impact on vac-
cine coverage and disease prevention.
5. Conclusion
Pregnant women who valued vaccination and trusted vaccine
information from academic institutions were more likely to refer
an educational app about vaccines to their close friends and family
than those who did not. Further research is needed to determine
the potential impact of this app referral strategy on vaccine cover-
age when implemented on a large scale.
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